The Impact of Trimetazidine Treatment on Left Ventricular Functions and Plasma Brain Natriuretic Peptide Levels in Patients with Non-ST Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

DEMIRELLI S., KARAKELLEOĞLU Ş., GÜNDOĞDU F., TAŞ M. H., Kaya A., Duman H., ...More

KOREAN CIRCULATION JOURNAL, vol.43, no.7, pp.462-467, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 43 Issue: 7
  • Publication Date: 2013
  • Doi Number: 10.4070/kcj.2013.43.7.462
  • Journal Name: KOREAN CIRCULATION JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.462-467
  • Keywords: Natriuretic peptide, brain, Percutaneous coronary intervention, Trimetazidine, FATTY-ACID OXIDATION, HEART-FAILURE, ARTERY-DISEASE, TRIMPOL-II, ANGINA, ISCHEMIA
  • Recep Tayyip Erdoğan University Affiliated: Yes

Abstract

Background and Objectives: The aim of this study was to investigate the impact of treatment with oral trimetazidine (TMZ) applied before and after percutaneous coronary interventions (PCI) on short-term left ventricular functions and plasma brain natriuretic peptide (BNP) levels in patients with non-ST segment elevation myocardial infarction (NSTEMI) undergoing PCI.